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The transcriptional co-regulator CBP (CREB-binding protein) has a highly conserved cysteine/histi-
dine-rich region (CH2) whose structure and function remain uncharacterized. Using nuclear mag-
netic resonance (NMR spectroscopy), sequence alignment, mass spectrometry, and mutagenesis,
we show that the CH2 domain is not a canonical plant homeodomain (PHD) ﬁnger, as previously
proposed, but binds an additional zinc atom through the region N-terminal to the putative PHD
motif. The CH2 domain and the preceding bromodomain interact and mutually stabilize each other,
implying a cooperative function. We tested the hypothesis that the bromodomain and the CH2
domain can interact with histones, but found that the CH2 does not participate in histone-
recognition.
Structured summary of protein interactions:
H4 binds to CBP by peptide array (View Interaction: 1, 2).
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
CREB-binding protein (CBP) and its paralog p300 are transcrip-
tional co-regulators that integrate numerous signal transduction
pathways and play critical roles in various cellular processes such
as cell proliferation, differentiation, apoptosis, and DNA repair [1].
Defects in CBP/p300 are implicated in a number of human diseases
including certain types of leukemia and lymphoma, gastric and
colorectal carcinomas, and congenital malformation syndromes
[2–5]. The biological functions of CBP and p300 are associated with
their ability to interact with a large number of proteins through
multiple protein-interaction domains as well as from the acetyl-
transferase activity associated with their histone acetyl transferase
(HAT) domains [6–8].
CBP and p300 have three cysteine/histidine rich zinc-binding
domains, termed CH1, CH2 and CH3 [9]. Although the CH1 and
CH3 domains have been well-characterized both structurally
and functionally, the structure and function of the cysteine/histi-
dine-rich region 2 (CH2) domain remains largely unknown. Based
on the presence of a conserved C4HC3 motif [10], it has beenproposed that the CH2 domain of CBP/p300 contains a consensus
plant homeodomain (PHD)-type zinc ﬁnger [11]. The CH2 domain
of CBP is located between the bromodomain (BRD), which func-
tions as an acetyl-lysine binding domain [12,13], and the HAT do-
main and is essential for acetylation of histones both in vitro and
in vivo [11,14]. It has been suggested that the BRD and the CH2
domain of p300 bind nucleosomes [15]. BRD and PHD domains
are frequently fused to each other and function in concert to read
multivalent histone marks [16]. However, it has not been estab-
lished whether the CH2 domain of CBP/p300 can recognize epige-
netic histone marks, although many other PHD ﬁngers have been
shown to recognize histone H3 with methylation of K4 or K9 or
with acetylation of K14 [17,18]. Whereas in most PHD–BRD cas-
settes in the human proteome, the PHD is N-terminal to the
BRD, in CBP/p300, the PHD is preceded by the BRD and a cysteine
rich linker.
Here we show, by sequence alignment, mass spectrometry, and
mutagenesis, that the CH2 domain of CBP does not contain a
canonical PHD domain but is an atypical zinc ﬁnger that binds
three zinc atoms. We report nuclear magnetic resonance (NMR)
and circular dichroism (CD) data that demonstrate that the BRD
and CH2 domains form an autonomous structural unit and that
each domain stabilizes the other. Using histone peptide arrays,
we also show that the BRD binds to histone H2B and H4 acetylation
marks whereas the CH2 domain does not recognize any additional
histone modiﬁcations.
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2.1. Preparation of proteins
The coding sequences for the BRD (residues 1079–1198) and
BRD–CH2 region (1079–1317) of mouse CBP were cloned into the
pGEX-4T2 vector between BamHI and XhoI sites. The GST-tagged
proteins were expressed in Escherichia coli BL21 (DE3) cells by IPTG
induction at 15C. The proteins were initially puriﬁed by afﬁnity
chromatography on a Glutathione Sepharose 4B column followed
by size-exclusion chromatography on a Sephacryl S-100 column.
GST-tagged proteins were used for the binding assays on MODi-
ﬁed™ Histone Peptide Arrays. For other experiments, the GST tag
was removed by thrombin cleavage and the resulting proteins
were puriﬁed using Glutathione Sepharose 4B and Sephacryl S-
100 chromatography columns. Potential zinc ligands in the BRD–
CH2 domain construct were mutated to Ser or Ala (C1200S,
C1201S, C1213S, C1214S, C1220S, H1236A, H1292A, and
H1298A) using QuikChange Site-Directed Mutagenesis Kits. Mu-
tant proteins were expressed and puriﬁed by the same protocol
as for the wild-type protein.
The CH2 domain (residues 1192–1318) and the CH2 domain
with N-terminal truncation (CH2DN, residues 1225–1315) of
mouse CBP were cloned into the pET-21a vector between NdeI
and BamHI sites. The proteins were expressed in E. coli BL21
(DE3) [DNAY] host cells by IPTG induction at 20C and puriﬁed
by ion-exchange chromatography using Q-Sepharose and size-
exclusion chromatography using Sephacryl S-100.
2.2. NMR spectroscopy
NMR data were collected on Bruker 800, 750, and 500 MHz
spectrometers at 30C unless otherwise speciﬁed. A 0.6 mM uni-
formly 15N,13C-labeled BRD sample in NMR buffer (25 mM Tris–
HCl, pH 7.0, 50 mM NaCl, 1 mM DTT in 90% H2O:10% 2H2O) was
used to record two-dimensional (2D) HSQC and three-dimensional
(3D) HNCA spectra. Backbone resonances of the BRD were assigned
from a 3D HNCA experiment at 20C, assisted by the deposited
assignment data (Biological Magnetic Resonance Data Bank id:
17392). A sample of 1 mM uniformly 15N,13C,2H-labeled BRD–
CH2 in NMR buffer (supplemented with 50 lM ZnSO4) was used
to obtain 2D TROSY, 3D HNCA, 3D HNCACB, 3D CBCA(CO)NH,
and 3D HNCO for backbone assignments. 1H–15N HSQC spectra
were also acquired for 246 lM CH2 and 134 lM CH2DN samples
in NMR buffer supplemented with 50 lM ZnSO4. For the BRD–
CH2 mutants, 1H–15N HSQC and 1H–15N TROSY spectra were ac-
quired using 200–600 lM samples. All NMR data were processed
and analyzed using NMRPipe [19] and Sparky [20].
2.3. Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded for 10 lM BRD
and 5 lM BRD–CH2 in 10 mM MES buffer (pH 6.7) containing
0.5 mM DTT using an Aviv model 202 CD spectrometer. Thermal
denaturation was monitored by recording the CD signal at
208 nm as a function of increasing temperature from 20 to
100C. Melting temperatures (Tms) were determined by ﬁtting
the raw data to the Boltzmann sigmoidal equation using QtiPlot
software. For the two phase thermal denaturation curve of BRD–
CH2, the data from 20 to 60C and the data from 55 to 100C were
separately used for ﬁtting.
2.4. Electrospray ionization-mass spectrometry (ESI-MS)
Puriﬁed BRD–CH2 was completely desalted using a NAP-10 col-
umn. 150 lM BRD–CH2 in 10 mM ammonium acetate was directlyinjected into an Agilent 1100 Series ESI-MS spectrometer. MS data
was acquired in positive ion mode using capillary voltage of 5000 V
and fragmentator voltage of 175 V. The mass spectrum collected
for m/z range of 1000–2500 was deconvoluted using Chemstation
software.
2.5. NMR studies of BRD–CH2 interactions with a histone H2BK15Ac
peptide
A histone H2B peptide (residues 1–20) acetylated at K15 was
prepared by solid-phase synthesis on a Perseptive Biosystems syn-
thesizer using Fmoc chemistry. The H2BK15Ac peptide was puri-
ﬁed by reversed phase HPLC. NMR experiments were performed
by acquiring 2D TROSY spectra of 0.1 mM 15N-labeled BRD–CH2
in NMR buffer containing 50 lM ZnSO4 in the presence or absence
of 1 mM H2BK15Ac peptide.
2.6. Histone binding assay
MODiﬁed™ Histone Peptide arrays were purchased from Active
Motif. Arrays were ﬁrst blocked by immersing in 10 mM Tris–HCl,
pH 7.4, 0.05% Tween 20, 150 mM NaCl, and 5% (w/v) non-fat dried
milk, and then incubated with 50 lM GST-BRD, 50 lM GST-BRD–
CH2, or 50 lM GST-BRD–CH2 with 1 mM H2BK15Ac peptide in
25 mM Tris–HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, and 50 lM
ZnSO4. Arrays were then treated with HRP-conjugated anti-GST
antibody (GenScript). Signals were detected using enhanced
chemiluminescence and captured by the FluorChem 8900 Imaging
System (AlphaInnotech).3. Results
3.1. The BRD and CH2 domains of CBP are associated
Two CBP constructs, one consisting of the isolated BRD and the
other containing both the BRD and the CH2 domains (BRD–CH2),
were expressed and labeled uniformly with 13C and 15N for NMR
spectroscopy. The backbone amide resonances of both constructs
were assigned using conventional triple-resonance experiments.
A 2D HSQC spectrum of the BRD and a 2D TROSY spectrum of
the BRD–CH2 construct with assignments are shown in the Supple-
mentary Fig. S1. We initially aimed to determine the structure of
the BRD–CH2 construct, but the NMR data are of insufﬁcient qual-
ity for structure determination. About 10% of backbone resonances
are missing and side-chain assignments could not be made, pre-
sumably due to a dynamic exchange process that broadens the
NMR signals and degrades the spectral resolution. However, we
could obtain important information about the organization of the
BRD and CH2 domains from the available backbone assignments.
A number of amide resonances of the BRD undergo large changes
in chemical shift or broaden out in the BRD–CH2 construct
(Fig. 1A and Supplementary Fig. S1C), showing that the two do-
mains associate with each other rather than behaving as indepen-
dent beads on a string. The interaction site has been mapped to the
opposite end of the BRD helical bundle from the binding site for
acetyl-lysine peptides (Fig. 1B).
We employed CD spectroscopy to investigate the thermal sta-
bility of the BRD in the presence and absence of the CH2 domain.
CD spectra of the BRD and BRD–CH2 constructs were measured
at 208 nm, which is a characteristic minimum for a-helical pro-
teins, as a function of increasing temperature. The BRD shows a
typical thermal denaturation pattern for a single domain with a
Tm of 41C (Fig. 2A). In contrast, the BRD–CH2 construct undergoes
two phase denaturation, with Tms of 49C and 72C (Fig. 2B). The
ﬁrst phase of denaturation of the BRD–CH2 occurs 8C higher than
Fig. 1. The BRD and the CH2 domain interact with each other. (A) A plot of chemical shift differences (Ddave) of the backbone HN and N resonances of the BRD of CBP between
the isolated BRD and BRD–CH2. The weighted average chemical shift change was calculated from the equation Ddave ¼ fðDdN=5Þ2 þ ðDdHNÞ2g
1=2
. Red bars indicate changes in
Ddave greater than 0.2. Residues whose resonances are completely broadened out due to the interaction are marked by orange asterisks. (B) Residues that exhibit signiﬁcant
perturbation are mapped on the structure of the BRD (PDB id: 1JSP) using the same color code as in (A).
Fig. 2. The BRD and the CH2 domain are more stable in BRD–CH2 than the isolated domains. Thermal denaturation of the BRD (A) and BRD–CH2 (B) measured by CD
spectroscopy. The CD values measured at 208 nm are plotted against temperature ranging from 20 to 100C. Open circles are raw data while the solid lines show the ﬁtted
values using a sigmoidal curve. (C) An overlay of a selected region of the HSQC spectra of the isolated CH2 domain (red) and BRD–CH2 (black), showing residues observed as
two peaks only in the spectrum of the CH2 domain. aThis peak in BRD–CH2 is from N1163.
2508 S. Park et al. / FEBS Letters 587 (2013) 2506–2511for the isolated BRD, suggesting that the BRD is stabilized against
thermal denaturation by fusion to the CH2 domain. The second
transition is most likely associated with denaturation of the CH2
domain, which we expect to have a high denaturation temperature
due to the coordination of zinc. Attempts to monitor thermal dena-
turation of the isolated CH2 domain by CD were unsuccessful.
However, 1H–15N HSQC spectra provide strong evidence that the
CH2 domain is stabilized by fusion to the BRD. Several residues,
including Y1229, S1230, E1239, C1241, F1242, E1269, and N1273,
exhibit split cross peaks in the HSQC spectrum of the isolated
CH2 domain, which implies that these residues adopt two different
conformations (Fig. 2C). Each of these residues gives rise to a single
cross peak in the HSQC spectrum of the BRD–CH2 construct. Addi-
tionally, the cross peaks of many residues are broadened in the
HSQC spectrum of the isolated CH2 domain due to conformational
exchange, but are readily observed in the spectrum of theBRD–CH2 construct. Thus, both the BRD and CH2 domain struc-
tures are mutually stabilized in the BRD–CH2 fusion construct rel-
ative to the isolated domains.
3.2. The CH2 domain of CBP is a non-canonical zinc ﬁnger that binds
three zinc atoms
It has been proposed that residues 1233–1315 of the CH2 do-
main of CBP/p300 constitute a PHD ﬁnger, which binds two zinc
atoms [10,11]. Unlike the canonical PHD motif, which forms a sta-
ble and independently folded globular structure, the C4HC3 region
of the CH2 domain does not fold independently. The entire CH2 do-
main, including the 33 amino acids N-terminal to the C4HC3 motif
of the putative PHD zinc ﬁnger, is required for formation of a folded
structure. The 1H–15N HSQC spectrum of CH2DN, which contains
only the C4HC3 motif, is poorly dispersed and many cross peaks
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well folded (Fig. 3A). In contrast, the full-length CH2 domain (res-
idues 1192–1318) shows a well-dispersed 1H–15N HSQC spectrum
characteristic of a folded protein (Fig. 3A). In addition, CH2DN
aggregated through mixed-disulﬁde formation which could be re-
versed by adding fresh reducing agent, suggesting that some of the
seven cysteines of CH2DN are not properly participating in zinc
coordination. From these results, we conclude that the N-terminal
33 amino acid extension to the C4HC3 motif is an integral part of
the CH2 domain structure. ESI-MS analysis of the BRD–CH2 con-
struct demonstrated the presence of three zinc atoms (Fig. 3B).
The difference between the observed mass (28465 Da) and the
mass calculated from the amino acid sequence (28,276 Da) isFig. 3. The CH2 domain of CBP requires three zinc atoms to fold properly. (A) An overlay
(red). (B) ESI-MS spectrum of the BRD–CH2 construct (top) and the deconvoluted spectr
Fig. 4. Sequence alignment of the CH2 domains of CBP and p300 homologs. Residues nu
throughout species are colored by residue types. Residues proposed to coordinate zin
P300_HUMAN, XP_001332718.3, NP_001088637.1, Q9W321_DROME, CBP1_CAEE
NP_001191640.1, XP_002156492.2, XP_003383601.1, XP_002572380.1, EGD72148.1, XP189 Da, which corresponds to the mass of three zinc atoms. There-
fore, the CH2 domain of CBP binds three zinc atoms and the N-ter-
minal extension of the CH2 domain is necessary for proper
coordination of zinc.
Alignment of available CBP/p300 sequences showed the pres-
ence of four invariant cysteine residues in the N-terminal exten-
sion preceding the C4HC3 motif of the CH2 domain (Fig. 4).
These residues are absolutely conserved in CBP homologs ranging
from single-celled organisms to plants and animals. In order to
conﬁrm that only the conserved cysteines and histidine are in-
volved in zinc binding, a number of single amino acid mutants
were prepared. Three of these mutants, C1213S, H1236A, and
H1298A, which are not conserved, expressed well as solubleof the 1H–15N HSQC spectra of the CH2DN (black) and the full-length CH2 domain
um that shows a component with a mass of 28465 Da (bottom).
mbers of mouse CBP are shown above the sequence. Completely conserved residues
c atoms are marked by asterisks. Sequences included are CBP/P300_MOUSE, CBP/
L, XP_311133.5, XP_002411559.1, EFX66192.1, XP_782558.3, EFA02517.1,
_004347654.1, XP_002179989.1, HAC1_ARATH, HACL3_ORYSJ.
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NMR experiments on these mutants revealed that they are cor-
rectly folded and give similar HSQC spectra to that of the wild-type
protein, proving that these residues are not involved in zinc-bind-
ing (Supplementary Fig. S2). In contrast, E. coli expression of other
mutants, C1200S, C1201S, C1214S, C1220S, and H1292A, in which
invariant cysteine or histidine residues were replaced, resulted in
mostly insoluble recombinant proteins. We interpret this as evi-
dence of misfolding due to substitution of ligands involved in zinc
binding. Assuming four ligand residues are necessary to bind each
zinc atom, all 11 invariant cysteines and the one invariant histidine
are required for binding three zinc atoms.
We used the available resonance assignments and the program
TALOS+ [21] to identify the secondary structure of the CH2 domain
for comparison with canonical PHD structures. The secondary
structure of the CH2 domain, within the BRD–CH2 construct, is
summarized in Supplementary Fig. S3. Canonical PHD motifs bind
two zinc atoms in a cross-brace topology and have a characteristic
antiparallel b-sheet formed by two short b-strands [17]. The sec-
ondary structure of the C4HC3 region of the CH2 domain differs
from the canonical PHD in three ways. Firstly, residues E1239–
E1244 of the C4HC3 region, spanning the ﬁrst zinc-binding CXXC
module, form a well-deﬁned helix that is not found in the PHD mo-
tif. Secondly, residues R1289-H1292 of CBP, which would form one
of the strands of the characteristic b-sheet of a PHD motif, do not
form a b-strand in the CH2 domain. Finally, residues G1247-
D1277 form a long structured insertion in place of a short loop con-
necting the ﬁrst pair of CXXC modules in the canonical PHD motif.
Thus, the C4HC3 region of CBP differs from the canonical PHD mo-
tif in both its secondary structure and its ability to fold as an inde-
pendent domain.
3.3. The BRD binds acetylated histone H2B and H4 peptides
Many PHD ﬁngers have been shown to be readers of epigenetic
histone marks [17]. To determine whether the CH2 domain of CBP
functions in recognition of modiﬁed histones, we screened for
binding using MODiﬁed™ Histone Peptide arrays from Active Mo-
tif. We used the GST-tagged BRD–CH2 construct for the assay and
compared the results with binding data for the isolated BRD using
a GST-BRD construct. The BRD–CH2 was observed to bind prefer-
entially to several acetylated histone H4 and H2B peptides
(Fig. 5A). However, the isolated BRD binds to the same set of H4Fig. 5. The BRD binds to H2B and H4 with acetylation whereas the CH2 domain does n
Peptide array of BRD–CH2 (left) and the BRD (right). Post-translational modiﬁcations for
Me2s: symmetric di-methylation, Me2a: asymmetric di-methylation. A full-region of the
An array of BRD–CH2 in the presence of the H2BK15Ac peptide.and H2B peptides (Fig. 5A). We also carried out a binding assay
of the BRD–CH2 using a histone H2B peptide with acetylation at
K15 (H2BK15Ac) in the assay buffer to see if the BRD and the
CH2 domains bind cooperatively to modiﬁcations on two separate
histone peptides. In this array, the BRD–CH2 did not recognize an
additional modiﬁcation and, instead, its binding to the acetylated
H2B and H4 peptides on the array became weaker because the
immobilized histone peptides have to compete with the free
H2BK15Ac peptide. In conﬁrmation of the results obtained with
histone arrays, only the BRD HSQC cross peaks were perturbed
upon addition of the H2BK15Ac peptide into 15N-labeled BRD–
CH2, indicating that the CH2 domain does not participate in his-
tone binding (Supplementary Fig. S4). Taken together, our data
indicate that the CH2 domain of CBP does not read an additional
epigenetic mark.
4. Discussion
Our data provide strong evidence that the CH2 domain of CBP is
not a PHD zinc ﬁnger but is a non-canonical zinc ﬁnger that binds
three zinc atoms. The entire CH2 sequence is required for forma-
tion of a stable folded structure in the presence of zinc. The N-ter-
minal extension to the putative PHD ﬁnger, which was previously
regarded as a linker between the BRD and PHD, appears to be an
integral part of the CH2 zinc ﬁnger, providing four additional li-
gands that accommodate one zinc atom. Zinc ﬁngers of MLL1 and
AF10, which were initially considered as PHD ﬁngers, have also a
cysteine/histidine-enriched N-terminal extension to the PHD-like
motif [22,23]. These zinc ﬁngers, arranging cysteine and histidines
as HC5HC2H, are now classiﬁed as a PHD-like zinc binding domain
in the PFAM database. However, the CH2 domain of CBP has no se-
quence similarity with those PHD-like zinc binding domains. Since
no PHD ﬁnger has been reported to have an extension that binds an
additional zinc atom, our results strongly suggest that the CH2 do-
main of CBP/p300 is a novel type of zinc ﬁnger.
The CH2 domain precedes the HAT domain in CBP homologs
ranging from single-celled organisms to plants and higher eukary-
otes. The N-terminus of CH2 that includes the additional zinc-bind-
ing cysteine residues contains a previously identiﬁed motif (PFAM
DUF902), which appears at the C-terminus of BRD domains in ani-
mal, but not plant, CBP homologs. We show that the DUF902 motif
is an integral part of the CH2 domain. The fact that the CH2 domain
is always associated with the HAT domain suggests that the CH2ot recognize any additional mark. (A) A selected region of the Modiﬁed™ Histone
the spots with a strong signal are shown below. Ac: acetylation, P: phosphorylation,
arrays and the complete list of modiﬁcations are shown in Supplementary data. (B)
S. Park et al. / FEBS Letters 587 (2013) 2506–2511 2511domain plays an important functional role in HAT domain activity.
A previous study has shown that the CH2 domain of CBP is essen-
tial for in vitro acetyltransferase activity and transcriptional activ-
ity and mutations in the CH2 domain are associated with loss of
acetyltransferase activity in Rubinstein-Taybi syndrome [11,14].
Based on our ﬁnding that the BRD and the CH2 domain of CBP asso-
ciate with each other, these two domains may also function in a
cooperative manner. Although it has been proposed that both the
BRD and the CH2 domain of p300 can interact with nucleosomes
that have a high degree of acetylation [15], we were unable to ﬁnd
any evidence to support a potential role for the CH2 domain in rec-
ognition of epigenetic histone marks. However, we cannot exclude
the possibility that the CH2 domain may bind to the nucleosome
core instead of tails, which should be addressed by further studies.
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